Pfizer/BioNTech show high immune response in a booster dose against Omicron in clinical trial for children 5-11 years

Article

Pfizer/BioNTech announce positive results for a third dose of their COVID-19 vaccine for children

Grant Paulsen, MD, assistant professor, Division of Infectious Disease, Department of Pediatrics, Cincinnati Children's Hospital Medical Center in Ohio, and primary investigator for the hospital's clinical trial for a third dose (booster) for the Pfizer/BioNTech vaccine for COVID-19, discusses what the data might mean for children aged 5 to 11 years.

Recent Videos
Tina Tan, MD
Robert Frenck, MD
Robert Frenck, MD | Image credit: Cincinnati Children's
Russell Libby, MD, FAAP
Lawrence Eichenfield, MD
COVID-19 Roundtable: Considering off label therapies
COVID-19 Therapy Roundtable: Focusing on Inpatient Care | Image credit: Production Perig
Image credit: Production Perig
Tina Tan, MD
Brittany Bruggeman, MD
Related Content
Tina Tan, MD

Tina Tan, MD, comments on a severe respiratory season, stresses timely vaccination

Joshua Fitch, Senior Editor
January 30th 2025
Article

Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses the severity of the current respiratory virus season and stresses the importance of vaccinations to protect against influenza, COVID-19, RSV, and more.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

Miranda Hester
August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

FDA accepts sNDA for higher regimen nusinersen for spinal muscular atrophy | Image Credit: © A Illustrations raki - © A Illustrations raki - stock.adobe.com.

FDA accepts sNDA for higher regimen nusinersen for spinal muscular atrophy

Joshua Fitch, Senior Editor
January 24th 2025
Article

The higher dose regimen of nusinersen comprises a more rapid loading regimen, two 50 mg doses 14 days apart, and higher maintenance regimen, 28 mg, every 4 months.

What Omicron could mean for the pandemic

What Omicron could mean for the pandemic

Miranda Hester
January 7th 2022
Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

FDA expands immobilized lipase cartridge approval down to 1 year old | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.

FDA expands immobilized lipase cartridge clearance down to 1 year

Joshua Fitch, Senior Editor
January 16th 2025
Article

The digestive enzyme cartridge is designed to mimic pancreatic lipase function.

Kyriakie Sarafoglou, MD | Image credit: Provided by Kyriakie Sarafoglou

Kyriakie Sarafoglou, MD, discusses crinecerfont FDA approval for congenital adrenal hyperplasia

Joshua Fitch, Senior Editor
January 14th 2025
Article

The lead clinical trial investigator for a phase 3 study of crinecerfont in pediatric CAH patients breaks down the December 2024 FDA approval.

© 2025 MJH Life Sciences

All rights reserved.